Massive Bio
PrivateLast Round
Corporate Funding
Jan 15, 2025
Total Funding Raised
$22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Massive Bio is a health technology company that provides an artificial intelligence-driven platform designed to connect cancer patients to biopharmaceutical clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Healthcare Analytics, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Massive Bio Comparables
Compare Massive Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leal Health | 88% | |
| SymphonyAI | 79% | |
| BEKhealth | 78% | |
Massive Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jan 15, 2025 | ||||
| Series B | Jun 3, 2022 | ||||
| Grant | Dec 17, 2020 | ||||
| Series A | Nov 3, 2020 | ||||
| Seed | May 2, 2019 | ||||
Seed | Sep 26, 2016 |
Key People
Founding team and executive leadership
Massive Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| UL Ventures | Seed |
| International Finance Corporation | Series B |
| KFW DEG | Series B |
| 500 Global | Seed |
| SiteGround Capital | Series B |
| Cavendish Impact Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Broadens access to clinical trials through collaboration.
- Mar 1, 2026
Leveraging OpenAI's GPT-4o and GPT-5 models.
Massive Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Massive Bio's valuation, stock price, and market status.